SAVVY Vaginal Gel

Alternative Name: C31G Vaginal Gel

Description: C31G Vaginal Gel (1%) has components myristamine oxide and cetyle betaine.

Product Details

User: Female

Hormonal: No

Delivery Method: Vaginal Gel

Duration Type: Short-acting

Active Pharmaceutical Ingredient (API):
  • myristamine oxide
  • cetyl betaine

Multipurpose Preventive Technology (MPT): Yes

Status Details

Developer: Adamis Pharmaceuticals

Project Phase: Pre-Clinical and Clinical Development

Development Stage: Phase III

Active Development: No

Additional Information

References:

  • ClinicalTrials.gov Identified NCT00274261

Vertical Tabs

Print